Galderma Raises Full-Year Sales Guidance for Second Time in Two Quarters
Galderma raised its full-year sales guidance after robust sales growth in the first nine months, particularly in its therapeutic dermatology division.
Swiss skincare company Galderma raised its full-year sales outlook for the second time in two quarters on Thursday, following strong growth in sales over the first nine months. Its therapeutic dermatology division was a particular driver.